You are here

Barcelona Clinical Trials Platform (BCTP)

In order to position Catalonia among the top five European regions for conducting clinical trials, the Barcelona Clinical Trials Platform (BCTP) brings together the main hospital research institutes in one platform to improve coordination, integration, quality, inclusiveness and speed of clinical research.

The BCTP cuts the time and effort needed to start up new trials, provinding clinical trials sponsors through 7 university hospitals and the national primary care network. he BCTP strives to bring together the interests of all the centers to make the most of synergies in clinical research and attract innovative therapies still in the early stages of development to Catalonia.

BCTP 568

In 2014, at the behest of the Catalan Ministry of HealthBiocat created the Barcelona Clinical Trials Platform (BCTP), which will put Catalonia among the top hubs in the world for conducting clinical research projects, whether promoted by private or public sponsors. It kicked off with 8 founding members and expects to expand in the middle term to include other research institutes and hospitals in Catalonia.

The BCTP is a gateway for clinical trials, with access to 5 million patients and 2.000 experienced researchers.



Capabilities of the BCTP

  • As of January 2015, there were 2,740 sites participating in clinical trials, with a total of 13,498 patients recruited. The vast majority of the patients were involved in phase III trials (44%), followed by those in phase IV (25%).
  • In total, BCTP features 2,000 experienced clinical-trial researchers.
  • 2,515 sites participating in clinical trials underway between 2012 and 2014, with 78% of participation in the pre-registration phases (phase I, II and III). The main areas in which trials are conducted include oncology (35%), infectious diseases (10%), respiratory diseases (7%) and neurodegenerative diseases (7%). 
  • 1,487 sites participating in clinical trials completed between 2012 and 2014, with 13,287 patients recruited
  • 55% of clinical trials conducted in Spain are submitted to Ethics Committees in Catalonia
  • The Barcelona Clinical Trials Platform brings toguether: VHIR (Vall d'Hebron Univerity Hospital), VHIO (Vall d'Hebron Univerity Hospital), IDIBAPS (Hospital Clínic Barcelona), IDIBELL (Bellvitge Hospital and Catalan Institute of Oncology [ICO] Hospitalet), IGTP (Hospital Germans Trias i Pujol), IMIM (Hospital del Mar), IIB Sant Pau (Hospital de la Santa Creu i Sant Pau) and IDIAP (Jordi Gol Institute for Research in Primary Care).


gràfics bctp



GENPRECIS.CAT  pilot program, an personalized medicine strategy, integrates key stakeholders like the Government of Catalonia – Catalan Ministry of Health, Biocat, BCTP research institutes, CNAG, BSC and Precise Genomics/UPF. This project proposes to use this knowledge to benefit patients in Catalonia with the participation and coordination of stakeholders in research and the healthcare system. This project will support oncologists in providing each patient with the best personalized treatment from information based on precise genomic knowledge of the patient.

bctp gen precis


You can find more information about the Barcelona Clinical Trials Platform on its website.



Membres BCTP

    Logo BCTP